Back to User profile » Dr Maria Buti

Papers published by Dr Maria Buti:


Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

Perales C, Chen Q, Soria ME, Gregori J, Garcia-Cehic D, Nieto-Aponte L, Castells L, Imaz A, Llorens-Revull M, Domingo E, Buti M, Esteban JI, Rodriguez-Frias F, Quer J

Infection and Drug Resistance 2018, 11:2207-2210

Published Date: 8 November 2018

HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection

Sarrazin C, Castelli F, Andreone P, Buti M, Colombo M, Pol S, Calinas F, Puoti M, Olveira A, Shiffman M, Stern JO, Kukolj G, Roehrle M, Aslanyan S, Deng Q, Vinisko R, Mensa FJ, Nelson DR

Clinical and Experimental Gastroenterology 2016, 9:351-363

Published Date: 24 November 2016